A comparative in vitro investigation on the cardiotoxicity of two tyrosine kinase inhibitors: Regorafenib and lenvatinib
Gunaydin, A., Boran, T., Jannuzzi, A.T., Alpertunga, B.
Published in Toxicology letters (10.10.2018)
Published in Toxicology letters (10.10.2018)
Get full text
Journal Article